Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.53 USD | -4.23% | +3.34% | -16.11% |
Apr. 15 | Morgan Stanley Adjusts Pharvaris' Price Target to $34 From $35, Keeps Overweight Rating | MT |
Apr. 12 | Pharvaris Files Mixed Shelf | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.11% | 1.27B | |
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+47.02% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |
- Stock Market
- Equities
- PHVS Stock
- News Pharvaris N.V.
- Wedbush Lowers Pharvaris' PT to $24 From $27, Increases Share Count Assumptions Following Q3 Update, Keeps Outperform Rating Ahead of CHAPTER-1 Data